FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:1500-1501 May 20, 1993 Number 20 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

To the Editor: In November 1992, Whitehall Laboratories replaced the inactive preservative ingredient phenylmercuric nitrate in some stocks of Preparation H suppositories, ointment, and cream. Reformulation was dictated not by new scientific evidence but by the need to conform to California's Safe Drinking Water and Toxic Enforcement Act of 1986 (Proposition 65)¹. The new formulations will contain nonmercurial preservatives and will be available only in states receiving merchandise from the company's western regional distribution center.

This minimal reformulation is highly important, because nationally distributed medication is being modified to meet the regulatory requirements of a single state.

Phenylmercuric nitrate, . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.